Literature DB >> 6401716

Reconstitution of apolipoprotein A-I from human high density lipoprotein with bovine brain sphingomyelin.

J B Swaney.   

Abstract

Reconstitution of apolipoprotein A-I was found to occur readily with bovine brain sphingomyelin (BBSM), with a maximum rate occurring at a temperature of 28 degrees C, a temperature approximating the phase transition temperature for this naturally occurring phospholipid. At BBSM:A-I weight ratios of 7.5:1 or less, a single recombinant product was observed which contained three A-I molecules per particle, which had a BBSM:A-I molar ratio of 360 to 1 and which appeared in the electron microscope as a discoidal complex with a thickness of 68 A and a diameter of 217 A. By these criteria, as well as by gel filtration, this product appears very similar to that obtained by recombination of A-I with phosphatidylcholine at elevated ratios of phospholipid/protein. No evidence was found for the existence of any BBSM:A-I complexes comparable to the smaller lecithin:A-I complex containing 200-250 mol of phospholipid and two A-I molecules per complex which has been previously reported. At BBSM:A-I ratios of 15:1 (w/w), a new type of complex was observed which was discoidal by electron microscopy but possessed a larger diameter (390 A) and higher phospholipid:protein molar ratio (535:1) than has been observed previously for recombinant complexes. The BBSM:A-I complexes were found to be significantly more resistant to denaturation by guanidine hydrochloride than the dimyristoyl phosphatidylcholine:A-I recombinant complexes. It is concluded that the mechanisms of interaction between apolipoprotein A-I and either bovine brain sphingomyelin or phosphatidylcholines are similar, but that the nature of the protein-lipid interactions with BBSM are such as to produce larger and more stable complexes than are observed with the phosphatidylcholines.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6401716

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  7 in total

1.  Metabolic fate of sphingomyelin of high-density lipoprotein in rat plasma.

Authors:  M Bentejac; M Bugaut; M C Delachambre; J Lecerf
Journal:  Lipids       Date:  1990-10       Impact factor: 1.880

2.  Influence of apolipoprotein (Apo) A-I structure on nascent high density lipoprotein (HDL) particle size distribution.

Authors:  Charulatha Vedhachalam; Palaniappan Sevugan Chetty; Margaret Nickel; Padmaja Dhanasekaran; Sissel Lund-Katz; George H Rothblat; Michael C Phillips
Journal:  J Biol Chem       Date:  2010-08-02       Impact factor: 5.157

3.  Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

Authors:  Y Yui; T Aoyama; H Morishita; M Takahashi; Y Takatsu; C Kawai
Journal:  J Clin Invest       Date:  1988-09       Impact factor: 14.808

4.  The terminal complement proteins C5b-9 augment binding of high density lipoprotein and its apolipoproteins A-I and A-II to human endothelial cells.

Authors:  K K Hamilton; P J Sims
Journal:  J Clin Invest       Date:  1991-12       Impact factor: 14.808

5.  Morphology and structure of lipoproteins revealed by an optimized negative-staining protocol of electron microscopy.

Authors:  Lei Zhang; James Song; Giorgio Cavigiolio; Brian Y Ishida; Shengli Zhang; John P Kane; Karl H Weisgraber; Michael N Oda; Kerry-Anne Rye; Henry J Pownall; Gang Ren
Journal:  J Lipid Res       Date:  2010-10-26       Impact factor: 5.922

Review 6.  Sphingomyelin in high-density lipoproteins: structural role and biological function.

Authors:  Roberto Martínez-Beamonte; Jose M Lou-Bonafonte; María V Martínez-Gracia; Jesús Osada
Journal:  Int J Mol Sci       Date:  2013-04-09       Impact factor: 5.923

7.  HDL-Mediated Lipid Influx to Endothelial Cells Contributes to Regulating Intercellular Adhesion Molecule (ICAM)-1 Expression and eNOS Phosphorylation.

Authors:  Mónica Muñoz-Vega; Felipe Massó; Araceli Páez; Gilberto Vargas-Alarcón; Ramón Coral-Vázquez; Jaime Mas-Oliva; Elizabeth Carreón-Torres; Óscar Pérez-Méndez
Journal:  Int J Mol Sci       Date:  2018-10-30       Impact factor: 5.923

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.